Kolmar Korea & Abbott Korea sign exclusive license of 2 CNS drugs

Published: 2016-08-05 09:46:33

Updated: 2016-08-05 09:46:33

On the 27^th, Kolmar Korea(President Dong-han Yoon) announced the company concluded an CMO(contract manufacturing organization) agreement of 2 types of central nervous system(CNS) drugs with a global pharmaceutical company, Abbott Korea, and decided to exclusively supply the entire products in Korea.

These CNS drugs developed are Aerica Cap containing pregabalin as the main substance and anothe...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.